In a report released on February 7, Kevin Heal from Argus Research maintained a Buy rating on Raymond James Financial (RJF – Research Report).

Uncover why the promises of the second Trump administration have contractors concerned about spending and acquisition funding ...

Shares of Raymond James Financial Inc. RJF slipped 2.99% to $162.42 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.67% to ...

This was the stock's second consecutive day of gains.

Analysts at Raymond James reduced their Q3 2025 EPS estimates for shares of Ero Copper in a research note issued to investors ...

LPL Financial welcomes a $345 million investment and planning team from Ameriprise as RayJay's employee advisor arm adds a ...

Raymond James is seeing a beneficial shift to advisory as well as recovering M&A activity, which may continue. Read why I ...

Big Tech earnings, a key Fed meeting, and Trump's first full week in office: What to know this week ...

Analyst Mark McLaughlin CFA of Bank of America Securities maintained a Buy rating on Raymond James Financial (RJF – Research Report), with a ...

Beauty (NYSE:ELF – Free Report) had its price target trimmed by Raymond James from $175.00 to $120.00 in a research report ...

Following similar moves by other large firms, Raymond James says quarterly advisor counts aren’t the most meaningful measure ...